tiprankstipranks
Trending News
More News >
Immunitybio Inc (DE:26CA)
NASDAQ:26CA
Germany Market

ImmunityBio (26CA) Income Statement

Compare
15 Followers

ImmunityBio Income Statement

Last quarter (Q4 2025), ImmunityBio's total revenue was $38.28M, an increase of 406.95% from the same quarter last year. In Q4, ImmunityBio's net income was $-61.94M. See ImmunityBio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 113.29M$ 14.74M$ 622.00K$ 240.00K$ 934.00K
Gross Profit
$ 112.53M$ 14.74M$ 622.00K$ 240.00K$ 934.00K
Operating Expenses
$ 368.56M$ 358.93M$ 362.87M$ 351.54M$ 331.21M
Depreciation and Amortization
$ 15.53M$ 17.55M$ 18.51M$ 18.26M$ 14.24M
EBITDA
$ -223.56M$ -264.43M$ -478.66M$ -351.88M$ -320.75M
Operating Income
$ -256.03M$ -344.18M$ -362.25M$ -351.30M$ -330.28M
Other Income/Expenses
$ -95.58M$ -69.46M$ -221.64M$ -65.99M$ -19.56M
Pretax Income
$ -351.61M$ -413.64M$ -583.89M$ -417.29M$ -349.84M
Net Income
$ -351.40M$ -413.56M$ -583.20M$ -416.57M$ -346.79M
Per Share Metrics
Basic EPS
$ -0.38$ -0.59$ -1.15$ -1.04$ -0.89
Diluted EPS
$ -0.38$ -0.62$ -1.15$ -1.04$ -0.89
Weighted Average Shares Outstanding
919.86M 697.31M 508.64M 399.90M 389.23M
Weighted Average Shares Outstanding (Diluted)
919.86M 700.44M 508.64M 399.90M 389.23M
Currency in USD

ImmunityBio Earnings and Revenue History